Tag: annual reporting

CMS Sunshine Reporting Underway; Additional Resources Available

As previously announced, Phase 2 Sunshine reporting to the Centers for Medicare & Medicaid Services (CMS) of payments and transfers of value provided by pharmaceutical, biotechnology and medical device manufacturers to physicians and teaching hospitals in the Open Payments system is currently underway and available until June 30th.  CMS has released the following three video […]

CMS Releases the First Sunshine Reporting Phase 2 Tutorial for Manufacturers and GPOs

As discussed in a blog post last week, the Centers for Medicare & Medicaid Services (CMS) released today the first of three tutorials for pharmaceutical, medical device and biotechnology manufacturers and group purchasing organizations (GPOs) related to Phase 2 reporting of payments and other transfers of value provided to physicians and […]

CMS RELEASES OPEN PAYMENTS REGISTRATION INFORMATION FOR PHYSICIANS AND TEACHING HOSPITALS; PHASE 2 TIMELINE FOR MANUFACTURERS AND GPOS

The Centers for Medicare & Medicaid Services (CMS) released today information regarding registration in the Open Payments system for physicians and teaching hospitals interested in reviewing and verifying data reported by pharmaceutical, biotechnology and medical device manufacturers and group purchasing organizations (GPOs) in connection with the Physician Payments Sunshine Law prior […]

CMS Releases Additional Materials Regarding Phase I of Sunshine Reporting

The Centers for Medicare & Medicaid Services (CMS) issued this week additional resources for Phase I of registration and Sunshine data reporting.  For more information regarding CMS’s two phased approach to registration and data reporting, see the blog posts here and here.  Specifically, CMS released the following materials: 30 page […]

Three More Manufacturer Settlements in Vermont

As we told you here, the Vermont Office of the Attorney General (“VT AG”) previously published 25 enforcement actions taken against manufacturers of pharmaceutical, biological and medical devices for failing to comply with the state’s Prescribed Products Disclosure Law, 18 V.S.A. §§ 4631, 4632.  The VT AG also posted three more recent […]

CMS Sunshine Updates – Webinar Slides, Reporting Specifications, Letter from Congress

There have been several recent and noteworthy developments related to Centers for Medicare & Medicaid Services (CMS) Open Payments.  As we told you here and here, CMS held a follow-up webinar this week to address additional questions related to Sunshine registration and reporting.  The slides from this webinar are available on the CMS Open Payments website.  Notably, […]

CMS Webinar #2 Regarding Sunshine Data Submission

The Centers for Medicare & Medicaid Services (CMS) held two webinars today for applicable manufacturers and applicable group purchasing organizations (GPOs) related to the Open Payments registration and data submission processes.  With regard to data submission, CMS announced that there are two resources that will be available: Submission File Specifications, which list the […]

CMS Webinar #1 Regarding Sunshine Registration

The Centers for Medicare & Medicaid Services (CMS) held two webinars today for applicable manufacturers and applicable group purchasing organizations (GPOs) related to the Open Payments registration and data submission processes.  With regard to registration, CMS informed manufacturers and GPOs that there will be a two-step process as follows: Registration with CMS […]

CMS Announces Certain Updates for 2014 Open Payments Data Collection

The Centers for Medicare and Medicaid Services (CMS) recently announced certain updates for the 2014 Open Payments data collection period.  These updates include: Publication of a 2014 teaching hospital list Establishment of 2014 de minimis reporting thresholds Clarification of 2014 submission file specifications Parties affected by the Open Payments program can […]

Vermont AG Posts 25 Enforcement Actions Related to State Transparency Law

Last week, the Vermont Office of the Attorney General (“VT AG”) published 25 enforcement actions recently taken against manufacturers of pharmaceutical, biological and medical devices for failing to comply with the state’s Prescribed Products Disclosure Law, 18 V.S.A. §§ 4631, 4632.  These are the first enforcement actions that the VT AG has […]